Rest Of Europe Compounding Pharmacy Market (2025-2030)

This research extensively used secondary sources, directories, and databases to gather valuable information for analyzing the global compounding pharmacy market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives of major market companies, and industry consultants, to obtain and verify critical qualitative and quantitative data and evaluate the market's growth prospects. The global market size estimated through secondary research was then validated and refined with inputs from primary research to determine the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

After an initial assessment of the global compounding pharmacy market landscape through secondary research, comprehensive primary research was conducted. This included in-depth interviews with market experts from the demand side, such as stakeholders from pharmaceutical and biotechnology companies, CROs, CMOs, and academic and research institutions. Additionally, interviews were held with key supply-side participants, including C-suite and senior executives, product managers, and marketing and sales leaders from leading manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews involved supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to understand market dynamics comprehensively.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both bottom-up and top-down approaches were used to estimate and validate the total size of the compounding pharmacy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• A list of the major global players operating in the compounding pharmacy market was generated.
• The revenues generated from their compounding pharmacy product have been determined through annual reports and secondary sources (including paid databases)
• The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.
• All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

Global Compounding Pharmacy Market Size: Bottom-up and Top-down Approach

Data Triangulation

After estimating the market size using the process described above, the total market was divided into several segments and subsegments. To finish the overall market analysis and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used where applicable. The data was triangulated by examining various factors and trends from both the demand and supply sides.